Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine



   thrombophilia
  

Disease ID 587
Disease thrombophilia
Definition
A disorder of HEMOSTASIS in which there is a tendency for the occurrence of THROMBOSIS.
Synonym
blood hyperviscosity
excessive blood clotting
hypercoaguability
hypercoagulabilities
hypercoagulability
hypercoagulability state
hypercoagulability state (finding)
hypercoagulability state, nos
hypercoagulability states
hypercoagulable
hypercoagulable state
hypercoagulable states
hypercoagulation
thrombophilia (disorder)
thrombophilia [disease/finding]
thrombophilias
DOID
UMLS
C0398623
MeSH
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:148)
C0040053  |  thrombosis  |  38
C0021390  |  inflammatory bowel disease  |  7
C0034065  |  pulmonary embolism  |  6
C0021831  |  bowel disease  |  6
C0035328  |  retinal vein occlusion  |  6
C0028754  |  obesity  |  5
C0020538  |  hypertension  |  5
C0020550  |  hyperthyroidism  |  5
C0023895  |  liver disease  |  5
C0027726  |  nephrotic syndrome  |  5
C0032914  |  preeclampsia  |  4
C0023895  |  liver diseases  |  4
C0010481  |  cushing's syndrome  |  4
C0026764  |  multiple myeloma  |  4
C0039730  |  thalassemia  |  4
C0002895  |  sickle cell disease  |  4
C0023890  |  cirrhosis  |  4
C0398623  |  thrombophilia  |  3
C0007113  |  rectal cancer  |  3
C0002878  |  hemolytic anemia  |  3
C0040034  |  thrombocytopenia  |  3
C0012739  |  disseminated intravascular coagulation  |  3
C0011847  |  diabetes  |  3
C0009402  |  colorectal cancer  |  3
C0021390  |  inflammatory bowel diseases  |  3
C0018801  |  heart failure  |  3
C0085278  |  antiphospholipid syndrome  |  3
C0042384  |  vasculitis  |  3
C0002871  |  anemia  |  3
C0242379  |  lung cancer  |  3
C0242666  |  protein s deficiency  |  3
C0006142  |  breast cancer  |  2
C0001418  |  adenocarcinoma  |  2
C0000809  |  recurrent miscarriage  |  2
C0041296  |  tuberculosis  |  2
C0007193  |  dilated cardiomyopathy  |  2
C0032461  |  polycythemia  |  2
C0007785  |  cerebral infarct  |  2
C0000786  |  miscarriage  |  2
C0002895  |  sickle cell anemia  |  2
C0398625  |  protein c deficiency  |  2
C0026265  |  mitral valve disease  |  2
C0007570  |  celiac disease  |  2
C0087086  |  thrombi  |  2
C0027051  |  myocardial infarct  |  2
C0155773  |  portal vein thrombosis  |  2
C0011849  |  diabetes mellitus  |  2
C0032463  |  polycythemia vera  |  2
C0040156  |  thyrotoxicosis  |  2
C0878544  |  cardiomyopathy  |  2
C0037198  |  sinus thrombosis  |  2
C0021359  |  infertility  |  2
C0022658  |  nephropathy  |  2
C0011570  |  depression  |  1
C0006666  |  calciphylaxis  |  1
C0162871  |  abdominal aortic aneurysm  |  1
C0020541  |  portal hypertension  |  1
C0272286  |  immune thrombocytopenia  |  1
C0007785  |  cerebral infarcts  |  1
C0398623  |  hypercoagulability  |  1
C0155686  |  acute myocarditis  |  1
C0004153  |  atherosclerosis  |  1
C0272375  |  antithrombin deficiency  |  1
C0271623  |  hypogonadotrophic hypogonadism  |  1
C0014175  |  endometriosis  |  1
C0013537  |  eclampsia  |  1
C0018802  |  congestive heart failure  |  1
C1619734  |  pulmonary arterial hypertension  |  1
C0033680  |  protein-losing enteropathy  |  1
C0264716  |  chronic heart failure  |  1
C0021053  |  immune disorder  |  1
C0035078  |  renal failure  |  1
C0001339  |  acute pancreatitis  |  1
C0162529  |  ischemic colitis  |  1
C0152013  |  lung adenocarcinoma  |  1
C0022661  |  end-stage renal disease  |  1
C0598608  |  hyperhomocysteinemia  |  1
C0221406  |  cushing's disease  |  1
C0238124  |  necrotizing fasciitis  |  1
C0149931  |  migraine  |  1
C0027059  |  myocarditis  |  1
C0035309  |  retinopathy  |  1
C0030305  |  pancreatitis  |  1
C0042373  |  vascular disorders  |  1
C0040028  |  essential thrombocythemia  |  1
C0042769  |  virus infection  |  1
C0497327  |  dementia  |  1
C0017665  |  membranous nephropathy  |  1
C0034150  |  purpura  |  1
C0003486  |  aortic aneurysm  |  1
C0010674  |  cystic fibrosis  |  1
C0011860  |  type 2 diabetes  |  1
C0042345  |  varicose vein  |  1
C0007115  |  thyroid cancer  |  1
C0021359  |  infertile  |  1
C0040053  |  thrombus  |  1
C0024314  |  lymphoproliferative disorder  |  1
C0032460  |  polycystic ovarian syndrome  |  1
C0024115  |  pulmonary disease  |  1
C0010072  |  coronary thrombosis  |  1
C0042974  |  von willebrand's disease  |  1
C0020619  |  hypogonadism  |  1
C0043117  |  immune thrombocytopenic purpura  |  1
C0598639  |  hypercortisolemia  |  1
C0039445  |  hereditary hemorrhagic telangiectasia  |  1
C0024117  |  chronic obstructive pulmonary disease  |  1
C0856761  |  budd-chiari syndrome  |  1
C0014118  |  endocarditis  |  1
C0011880  |  diabetic ketoacidosis  |  1
C0041234  |  chagas disease  |  1
C0021053  |  immune disease  |  1
C1700942  |  idiopathic pulmonary arterial hypertension  |  1
C0036341  |  schizophrenia  |  1
C0026764  |  myeloma  |  1
C0024796  |  marfan syndrome  |  1
C0020542  |  pulmonary hypertension  |  1
C0023890  |  liver cirrhosis  |  1
C0023234  |  perthes disease  |  1
C0948265  |  metabolic syndrome  |  1
C0000786  |  miscarriages  |  1
C0836924  |  thrombocythemia  |  1
C0027051  |  myocardial infarction (mi)  |  1
C0024299  |  lymphoma  |  1
C0085650  |  purpura fulminans  |  1
C0005283  |  beta thalassemia  |  1
C0007785  |  cerebral infarction  |  1
C0035854  |  rosacea  |  1
C0042373  |  vascular disorder  |  1
C0011860  |  type 2 diabetes mellitus  |  1
C0154841  |  central retinal vein occlusion  |  1
C0042373  |  vascular disease  |  1
C0014130  |  endocrinopathy  |  1
C0600260  |  obstructive pulmonary disease  |  1
C0085083  |  ovarian hyperstimulation syndrome  |  1
C0343525  |  lemierre syndrome  |  1
C0162739  |  hellp syndrome  |  1
C0221390  |  nonbacterial thrombotic endocarditis  |  1
C0376358  |  prostate cancer  |  1
C0007115  |  thyroid ca  |  1
C0027051  |  myocardial infarction  |  1
C0042345  |  varicose veins  |  1
C0024314  |  lymphoproliferative disorders  |  1
C0035335  |  retinoblastoma  |  1
C0022658  |  renal disease  |  1
C0836924  |  thrombocytosis  |  1
C0007785  |  cerebral infarctions  |  1
C0155626  |  acute myocardial infarction  |  1
C0019069  |  hemophilia  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:15)
5624  |  PROC  |  UniProtKB-KW
2158  |  F9  |  UniProtKB-KW
2153  |  F5  |  UniProtKB-KW
4524  |  MTHFR  |  CTD_human
2147  |  F2  |  CLINVAR;CTD_human;UniProtKB-KW
2243  |  FGA  |  CTD_human
7056  |  THBD  |  CTD_human;UniProtKB-KW
51156  |  SERPINA10  |  CTD_human
2157  |  F8  |  CTD_human
11093  |  ADAMTS13  |  GHR
5627  |  PROS1  |  UniProtKB-KW;GHR
5340  |  PLG  |  UniProtKB-KW
3026  |  HABP2  |  CTD_human
3273  |  HRG  |  UniProtKB-KW
3053  |  SERPIND1  |  CTD_human
Inferring Gene
Entrez_id | Symbol | Resource(Total Genes:14)
2147  |  F2  |  CIPHER;CTD_human
2153  |  F5  |  CIPHER
2244  |  FGB  |  CIPHER
3690  |  ITGB3  |  CIPHER
3717  |  JAK2  |  CIPHER
4524  |  MTHFR  |  CIPHER;CTD_human
462  |  SERPINC1  |  CIPHER
5054  |  SERPINE1  |  CIPHER
7056  |  THBD  |  CIPHER;CTD_human
2243  |  FGA  |  CTD_human
51156  |  SERPINA10  |  CTD_human
3026  |  HABP2  |  CTD_human
2157  |  F8  |  CTD_human
3053  |  SERPIND1  |  CTD_human
Text Mined Gene
Entrez_id | Symbol | Score | Resource(Total Genes:102)
2  |  A2M  |  3.436  |  DISEASES
11093  |  ADAMTS13  |  7.893  |  DISEASES
80070  |  ADAMTS20  |  1.03  |  DISEASES
9719  |  ADAMTSL2  |  1.068  |  DISEASES
174  |  AFP  |  1.179  |  DISEASES
302  |  ANXA2  |  2.106  |  DISEASES
282991  |  BLOC1S2  |  2.136  |  DISEASES
114899  |  C1QTNF3  |  4.07  |  DISEASES
721  |  C4B  |  4.685  |  DISEASES
722  |  C4BPA  |  1.059  |  DISEASES
875  |  CBS  |  1.792  |  DISEASES
930  |  CD19  |  1.176  |  DISEASES
914  |  CD2  |  1.116  |  DISEASES
959  |  CD40LG  |  3.618  |  DISEASES
966  |  CD59  |  1.873  |  DISEASES
1029  |  CDKN2A  |  1.104  |  DISEASES
752014  |  CEMP1  |  1.169  |  DISEASES
629  |  CFB  |  1.295  |  DISEASES
3075  |  CFH  |  2.686  |  DISEASES
3426  |  CFI  |  2.453  |  DISEASES
285440  |  CYP4V2  |  1.561  |  DISEASES
28514  |  DLL1  |  1.017  |  DISEASES
55741  |  EDEM2  |  1.762  |  DISEASES
2120  |  ETV6  |  1.288  |  DISEASES
2159  |  F10  |  4.197  |  DISEASES
2160  |  F11  |  4.132  |  DISEASES
2165  |  F13B  |  2.268  |  DISEASES
2149  |  F2R  |  2.241  |  DISEASES
2152  |  F3  |  7.137  |  DISEASES
2153  |  F5  |  5.708  |  DISEASES
2155  |  F7  |  5.118  |  DISEASES
2157  |  F8  |  4.797  |  DISEASES
26232  |  FBXO2  |  1.033  |  DISEASES
26270  |  FBXO6  |  1.385  |  DISEASES
2224  |  FDPS  |  4.211  |  DISEASES
2266  |  FGG  |  3.121  |  DISEASES
387758  |  FIBIN  |  1.842  |  DISEASES
51661  |  FKBP7  |  1.293  |  DISEASES
2811  |  GP1BA  |  2.682  |  DISEASES
3030  |  HADHA  |  4.18  |  DISEASES
3043  |  HBB  |  1.487  |  DISEASES
3146  |  HMGB1  |  2.246  |  DISEASES
3240  |  HP  |  2.981  |  DISEASES
3586  |  IL10  |  1.719  |  DISEASES
133396  |  IL31RA  |  1.612  |  DISEASES
3632  |  INPP5A  |  1.46  |  DISEASES
387755  |  INSC  |  1.057  |  DISEASES
25896  |  INTS7  |  1.419  |  DISEASES
3684  |  ITGAM  |  1.427  |  DISEASES
3717  |  JAK2  |  2.886  |  DISEASES
554203  |  JPX  |  1.562  |  DISEASES
102723508  |  KANTR  |  1.655  |  DISEASES
3767  |  KCNJ11  |  1.97  |  DISEASES
9622  |  KLK4  |  3.135  |  DISEASES
84247  |  LDOC1L  |  1.888  |  DISEASES
4151  |  MB  |  2.891  |  DISEASES
4311  |  MME  |  1.171  |  DISEASES
51253  |  MRPL37  |  3.026  |  DISEASES
4524  |  MTHFR  |  6.368  |  DISEASES
4564  |  MT-TH  |  1.085  |  DISEASES
4576  |  MT-TT  |  1.445  |  DISEASES
5049  |  PAFAH1B2  |  1.274  |  DISEASES
23481  |  PES1  |  2.357  |  DISEASES
5251  |  PHEX  |  3.641  |  DISEASES
57649  |  PHF12  |  1.665  |  DISEASES
5277  |  PIGA  |  1.834  |  DISEASES
5569  |  PKIA  |  1.187  |  DISEASES
5328  |  PLAU  |  2.098  |  DISEASES
23275  |  POFUT2  |  1.261  |  DISEASES
84106  |  PRAM1  |  1.348  |  DISEASES
5627  |  PROS1  |  4.872  |  DISEASES
122183  |  PRR20A  |  1.473  |  DISEASES
92241  |  RCSD1  |  1.238  |  DISEASES
6281  |  S100A10  |  1.766  |  DISEASES
6401  |  SELE  |  2.469  |  DISEASES
123228  |  SENP8  |  1.122  |  DISEASES
5265  |  SERPINA1  |  2.855  |  DISEASES
5104  |  SERPINA5  |  3.64  |  DISEASES
462  |  SERPINC1  |  7.941  |  DISEASES
5345  |  SERPINF2  |  5.487  |  DISEASES
6473  |  SHOX  |  1.333  |  DISEASES
23539  |  SLC16A8  |  1.266  |  DISEASES
1468  |  SLC25A10  |  1.458  |  DISEASES
83650  |  SLC35G5  |  2.146  |  DISEASES
6736  |  SRY  |  2.048  |  DISEASES
8676  |  STX11  |  1.11  |  DISEASES
2054  |  STX2  |  1.432  |  DISEASES
6818  |  SULT1A3  |  2.759  |  DISEASES
445329  |  SULT1A4  |  2.784  |  DISEASES
54790  |  TET2  |  1.165  |  DISEASES
7056  |  THBD  |  6.508  |  DISEASES
7058  |  THBS2  |  1.409  |  DISEASES
7124  |  TNF  |  2.981  |  DISEASES
340205  |  TREML1  |  2.442  |  DISEASES
90121  |  TSR2  |  2.297  |  DISEASES
7422  |  VEGFA  |  1.276  |  DISEASES
79001  |  VKORC1  |  1.233  |  DISEASES
89891  |  WDR34  |  1.425  |  DISEASES
23038  |  WDTC1  |  2.828  |  DISEASES
55906  |  ZC4H2  |  1.081  |  DISEASES
7718  |  ZNF165  |  1.006  |  DISEASES
7639  |  ZNF85  |  1.758  |  DISEASES
Locus(Waiting for update.)
Disease ID 587
Disease thrombophilia
Integrated Phenotype(Waiting for update.)
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:98)
HP:0001907  |  Thromboembolic disease  |  27
HP:0004936  |  Blood clot in vein  |  10
HP:0001297  |  Cerebral vascular events  |  9
HP:0000822  |  Hypertension  |  7
HP:0002625  |  Blood clot in a deep vein  |  6
HP:0012636  |  Retinal vein occlusion  |  6
HP:0000100  |  Nephrosis  |  6
HP:0002204  |  Pulmonary embolism  |  6
HP:0002664  |  Neoplasia  |  5
HP:0001513  |  Obesity  |  5
HP:0000836  |  Overactive thyroid  |  5
HP:0005305  |  Cerebral vein thrombosis  |  5
HP:0100602  |  Pre-eclampsia  |  4
HP:0001394  |  Hepatic cirrhosis  |  4
HP:0006775  |  Multiple myeloma  |  4
HP:0010885  |  Aseptic necrosis  |  4
HP:0002140  |  Ischemic stroke  |  4
HP:0001878  |  Haemolytic anaemia  |  3
HP:0005521  |  Disseminated intravascular coagulation  |  3
HP:0100806  |  Sepsis  |  3
HP:0011874  |  Heparin-induced thrombocytopenia  |  3
HP:0002617  |  Aneurysmal dilatation  |  3
HP:0100724  |  Hypercoagulability  |  3
HP:0001873  |  Low platelet count  |  3
HP:0001903  |  Anemia  |  3
HP:0002633  |  Vasculitis  |  3
HP:0001635  |  Congestive heart failure  |  3
HP:0003613  |  Antiphospholipid antibodies  |  3
HP:0005543  |  Reduced protein C activity  |  2
HP:0001511  |  Prenatal onset growth retardation  |  2
HP:0001901  |  Abnormally shaped erythrocytes  |  2
HP:0001638  |  Cardiomyopathy  |  2
HP:0000112  |  Nephropathy  |  2
HP:0001644  |  Congestive cardiomyopathy  |  2
HP:0003002  |  Breast carcinoma  |  2
HP:0030242  |  Blood clot in portal vein  |  2
HP:0002608  |  Celiac disease  |  2
HP:0000789  |  Infertility  |  2
HP:0000819  |  Diabetes mellitus  |  2
HP:0030247  |  Blood clot in splanchnic vein  |  2
HP:0002665  |  Lymphoma  |  1
HP:0030731  |  Carcinoma  |  1
HP:0000979  |  Purpura  |  1
HP:0003256  |  Coagulopathy  |  1
HP:0001733  |  Pancreatic inflammation  |  1
HP:0000716  |  Depression  |  1
HP:0012125  |  Prostate cancer  |  1
HP:0003774  |  End-stage renal failure  |  1
HP:0000010  |  Frequent urinary tract infections  |  1
HP:0001735  |  Acute pancreatitis  |  1
HP:0000083  |  Renal insufficiency  |  1
HP:0004420  |  Arterial thrombosis  |  1
HP:0002092  |  Pulmonary artery hypertension  |  1
HP:0011157  |  Auras  |  1
HP:0005318  |  Cerebral vasculitis  |  1
HP:0002076  |  Migraine headaches  |  1
HP:0002243  |  Protein-losing enteropathy  |  1
HP:0004850  |  Recurrent deep vein thrombosis  |  1
HP:0003201  |  Rhabdomyolysis  |  1
HP:0004942  |  Aortic aneurysm  |  1
HP:0000833  |  Glucose intolerance  |  1
HP:0000726  |  Dementia  |  1
HP:0030009  |  Incompetent cervix  |  1
HP:0030078  |  Lung adenocarcinoma  |  1
HP:0001693  |  Cardiac shunt  |  1
HP:0009919  |  Retinoblastoma  |  1
HP:0001973  |  Autoimmune thrombocytopenia  |  1
HP:0001944  |  Dehydration  |  1
HP:0004953  |  Abdominal aortic aneurysm  |  1
HP:0000488  |  Noninflammatory retina disease  |  1
HP:0012416  |  Hypercarbia  |  1
HP:0000044  |  Hypogonadotrophic hypogonadism  |  1
HP:0005523  |  Lymphoproliferative disorder  |  1
HP:0002619  |  Varicose veins  |  1
HP:0001892  |  Bleeding diathesis  |  1
HP:0001658  |  Myocardial infarction  |  1
HP:0000135  |  Hypogonadism  |  1
HP:0005110  |  Atrial fibrillation  |  1
HP:0030127  |  Endometriosis  |  1
HP:0012819  |  Myocarditis  |  1
HP:0001409  |  Portal hypertension  |  1
HP:0004755  |  Supraventricular tachycardia  |  1
HP:0100584  |  Endocarditis  |  1
HP:0001894  |  Thrombocytosis  |  1
HP:0040236  |  Hyperfibrinolysis  |  1
HP:0001695  |  Cardiac arrest  |  1
HP:0004941  |  Extrahepatic portal hypertension  |  1
HP:0001928  |  Abnormal blood coagulation studies  |  1
HP:0011165  |  Visual auras  |  1
HP:0006510  |  Chronic obstructive pulmonary disease  |  1
HP:0002960  |  Autoimmune condition  |  1
HP:0004934  |  Vascular calcification  |  1
HP:0001953  |  Diabetic ketosis  |  1
HP:0100753  |  Schizophrenia  |  1
HP:0002621  |  Atherosclerosis  |  1
HP:0012578  |  Membranous glomerulonephritis  |  1
HP:0100601  |  Eclampsia  |  1
HP:0030692  |  Brain tumor  |  1
Disease ID 587
Disease thrombophilia
Manually Symptom
UMLS  | Name(Total Manually Symptoms:12)
C1962958  |  hematoma
C1260903  |  dysfibrinogenemia
C0598608  |  hyperhomocysteinaemia
C0584960  |  factor v leiden mutation
C0524702  |  pulmonary thromboembolism
C0517555  |  venous thrombosis
C0155773  |  portal vein thrombosis
C0042373  |  vascular diseases
C0040053  |  thrombosis
C0040038  |  thromboembolism
C0033117  |  priapism
C0005779  |  coagulation defect
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:7)
C0040053  |  thrombosis  |  33
C0040038  |  thromboembolism  |  10
C0042487  |  venous thrombosis  |  3
C0038454  |  stroke  |  2
C0524702  |  pulmonary thromboembolism  |  1
C0398623  |  thrombophilia  |  1
C0584960  |  factor v leiden mutation  |  1
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
Text Mining Genotype(Total Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:38)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs1019731207340643479IGF1umls:C0398623GAD[A large-scale candidate gene association study of age at menarche and age at natural menopause.]0.0023670322010IGF112102470647CA
rs121918027237721665340PLGumls:C0398623BeFreeAfter returning to Korea he was tested for thrombophilia which revealed decreased activity of plasminogen and subsequent analysis of PLG gene showed heterozygous Ala620Thr mutation.0.0038001862013PLG6160738593GA
rs1590207340647040TGFB1umls:C0398623GAD[A large-scale candidate gene association study of age at menarche and age at natural menopause.]0.0023670322010TGFBR1999153883TG
rs1799963NA2147F2umls:C0398623CLINVARNA0.427144187NAF21146739505GA
rs222758919229049462SERPINC1umls:C0398623GAD[Functional consequences of the prothrombotic SERPINC1 rs2227589 polymorphism on antithrombin levels.]0.0077199252009SERPINC11173917078CT
rs2697679207340644683NBNumls:C0398623GAD[A large-scale candidate gene association study of age at menarche and age at natural menopause.]0.0023670322010NBN889937652AC
rs271924207340645122PCSK1umls:C0398623GAD[A large-scale candidate gene association study of age at menarche and age at natural menopause.]0.0023670322010PCSK1;LOC101929710596401720AT
rs3730043175745201636ACEumls:C0398623BeFreeGenetic polymorphisms associated with thrombophilia such as factor V Leiden, prothrombin G20210A, MTHFR C677T, ACE and PIA1/A2 may be the cause of the hypercoagulability that results in CVT.0.0129209272008ACE1763491216CT
rs3730043175745202153F5umls:C0398623BeFreeGenetic polymorphisms associated with thrombophilia such as factor V Leiden, prothrombin G20210A, MTHFR C677T, ACE and PIA1/A2 may be the cause of the hypercoagulability that results in CVT.0.120193262008ACE1763491216CT
rs386626619172637833717JAK2umls:C0398623BeFreeAmong the patients without overt CMD or thrombophilia and with unprovoked thrombosis, 29.4% (95% CI 16.8-46.1) with splanchnic venous thrombosis and 42.8% (95% CI 24.4-63.4) with PVT had the JAK2 V617F mutation.0.0140066952007NANANANANA
rs386626619193367363717JAK2umls:C0398623BeFreeInfluence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia.0.0140066952009NANANANANA
rs386626619187962513717JAK2umls:C0398623BeFreeAccordingly, it seems that the investigation for the V617F mutation of the JAK2 gene is not mandatory in all Mexican mestizo patients with unexplained thrombophilia and that this genetic study should be reserved for special cases, such as patients with thrombosis in uncommon sites or patients with cell counts suggesting the presence of an underlying MPD.0.0140066952008NANANANANA
rs386626619187687823717JAK2umls:C0398623BeFreeWe used the thrombin generation assay to evaluate the hypercoagulable state according to JAK2(V617F) mutational status in essential thrombocythemia (ET) and polycythemia vera (PV) patients.0.0140066952008NANANANANA
rs386626619212320033717JAK2umls:C0398623BeFreeImpact of common thrombophilias and JAK2 V617F on pregnancy outcomes in unselected Italian women.0.0140066952011NANANANANA
rs386626619239419683717JAK2umls:C0398623BeFreeA work-up for JAK2 V617F mutation and thrombophilia was done.0.0140066952014NANANANANA
rs387907201NA2147F2umls:C0398623CLINVARNA0.427144187NAF21146739326GT
rs397507444187964595054SERPINE1umls:C0398623BeFreeThe authors used polymerase chain reaction (PCR) measures for thrombophilia (FVL, PTG, C677T-A1298C methylenetetrahydrofolate reductase [MTHFR], platelet glycoprotein PLA1A2) and hypofibrinolysis (plasminogen activator inhibitor-1 4G4G).0.023093762009MTHFR111794407TG
rs397507444187964594524MTHFRumls:C0398623BeFreeThe authors used polymerase chain reaction (PCR) measures for thrombophilia (FVL, PTG, C677T-A1298C methylenetetrahydrofolate reductase [MTHFR], platelet glycoprotein PLA1A2) and hypofibrinolysis (plasminogen activator inhibitor-1 4G4G).0.2162964442009MTHFR111794407TG
rs397507444221732394524MTHFRumls:C0398623BeFreePlacenta slides of 65 IUFDs with known maternal thrombophilia test results (compound MTHFR C677T and A1298C heterozygosity, n = 10; MTHFR 677TT homozygosity, n = 3; protein S deficiency, n = 0; factor V Leiden mutation, n = 2; prothrombin gene mutation G20210A, n = 1; lupus anticoagulant, n = 2; antiphospholipid syndrome, n = 1; MTHFR C677T heterozygosity, n = 5; MTHFR A1298C heterozygosity, n = 4; and MTHFR 1298CC homozygosity, n = 2) and of 30 livebirths with positive maternal thrombophilia test results (n = 5, 2, 0, 9, 2, 0, 2, 7, 2 and 1, respectively, for those thrombophilias) were microscopically examined for septation, fetal vessel thrombosis, intimal fibrin cushions, avascular villi, haemorrhagic endovasculitis and fibromuscular sclerosis.0.2162964442012MTHFR111794407TG
rs397507444160154084524MTHFRumls:C0398623BeFreeThe case with factor VIII of 160% had two other thrombophilias (compound MTHFR C677T-A1298C heterozygosity, resistance to activated protein C), and hypofibrinolytic high Lp(a).0.2162964442005MTHFR111794407TG
rs397507444160154081351COX8Aumls:C0398623BeFreeThe case with factor VIII of 160% had two other thrombophilias (compound MTHFR C677T-A1298C heterozygosity, resistance to activated protein C), and hypofibrinolytic high Lp(a).0.0027144192005MTHFR111794407TG
rs397507444231570444524MTHFRumls:C0398623BeFreeThe aim of this study was to verify whether FV Leiden, PT G20210A, MTHFR C667T or MTHFR A1298C mutations influence the risk of recurrent fetal loss in a sample of Turkish women who had experienced recurrent fetal loss and to evaluate whether the aforementioned thrombophilias and recurrent fetal loss may affect the birth weight of subsequent pregnancies.0.2162964442012MTHFR111794407TG
rs397507444181605914524MTHFRumls:C0398623BeFreeSevere arterial thrombophilia associated with a homozygous MTHFR gene mutation (A1298C) in a young man with Klinefelter syndrome.0.2162964442008MTHFR111794407TG
rs41322052188299204846NOS3umls:C0398623BeFreeLimited by the small numbers of patients with multifocal osteonecrosis, this exploratory study suggested that thrombophilia was associated with both idiopathic multifocal osteonecrosis and secondary multifocal osteonecrosis, as was the eNOS T-786C polymorphism.0.0077298562008NOS37150993018CT
rs4135280207340645468PPARGumls:C0398623GAD[A large-scale candidate gene association study of age at menarche and age at natural menopause.]0.0023670322010PPARG312407495TC
rs4939833207340644092SMAD7umls:C0398623GAD[A large-scale candidate gene association study of age at menarche and age at natural menopause.]0.0023670322010SMAD71848941590TC
rs494958207340646715SRD5A1umls:C0398623GAD[A large-scale candidate gene association study of age at menarche and age at natural menopause.]0.0023670322010SRD5A156639066AT
rs6025233305082153F5umls:C0398623BeFreeFactor V Leiden (R507Q) and factor II (prothrombin) mutation (G20210A) are the two most common inherited hypercoagulability disorders among populations of European origin.0.120193262012F51169549811CT
rs627920734064255239ANKK1umls:C0398623GAD[A large-scale candidate gene association study of age at menarche and age at natural menopause.]0.0023670322010DRD211113410351GC
rs7586601207340648890EIF2B4umls:C0398623GAD[A large-scale candidate gene association study of age at menarche and age at natural menopause.]0.0023670322010LOC105374363227361799AG
rs77375493193367363717JAK2umls:C0398623BeFreeInfluence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia.0.0140066952009JAK2;INSL695073770GA,T
rs77375493187962513717JAK2umls:C0398623BeFreeAccordingly, it seems that the investigation for the V617F mutation of the JAK2 gene is not mandatory in all Mexican mestizo patients with unexplained thrombophilia and that this genetic study should be reserved for special cases, such as patients with thrombosis in uncommon sites or patients with cell counts suggesting the presence of an underlying MPD.0.0140066952008JAK2;INSL695073770GA,T
rs77375493172637833717JAK2umls:C0398623BeFreeAmong the patients without overt CMD or thrombophilia and with unprovoked thrombosis, 29.4% (95% CI 16.8-46.1) with splanchnic venous thrombosis and 42.8% (95% CI 24.4-63.4) with PVT had the JAK2 V617F mutation.0.0140066952007JAK2;INSL695073770GA,T
rs77375493187687823717JAK2umls:C0398623BeFreeWe used the thrombin generation assay to evaluate the hypercoagulable state according to JAK2(V617F) mutational status in essential thrombocythemia (ET) and polycythemia vera (PV) patients.0.0140066952008JAK2;INSL695073770GA,T
rs77375493212320033717JAK2umls:C0398623BeFreeImpact of common thrombophilias and JAK2 V617F on pregnancy outcomes in unselected Italian women.0.0140066952011JAK2;INSL695073770GA,T
rs77375493239419683717JAK2umls:C0398623BeFreeA work-up for JAK2 V617F mutation and thrombophilia was done.0.0140066952014JAK2;INSL695073770GA,T
rs909253207340647124TNFumls:C0398623GAD[A large-scale candidate gene association study of age at menarche and age at natural menopause.]0.0050055062010LTA;LOC100287329631572536AG
rs9457827207340643482IGF2Rumls:C0398623GAD[A large-scale candidate gene association study of age at menarche and age at natural menopause.]0.0023670322010IGF2R6160082624CT
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:8)
CHR POS SNPID REF ALT ORI_SNPID PMID P_VALUE P_VALUE_TEXT OR/BETA CI95_TEXT GWAS_INITIAL_SAMPLE_SIZE SUB_POPULATION SUPER_POPULATION GWAS_TRAIT HPO_ID HPO_TERM DO_ID DO_TERM MESH_ID MESH_TERM EFO_ID EFO_TERM DOLITE_TERM RISK_ALLELE PUBLICATION_TYPE AA GENE_SYMBOL TYPE REFGENE
3186445052rs2304456TGrs2304456227010190.000486NANANA339 European ancestry individuals from 21 familiesEuropean(339)ALL(339)EUR(339)ALL(339)Plasma factor XI level and activated partial thromboplastin timeHPOID:0001907HPOID:0004936ThromboembolismVenous thrombosisDOID:2452thrombophiliaNANANANAThrombophiliaNAResearch Support, Non-U.S. Gov't
3186451236rs4686799TCrs4686799227010190.000000167NANANA339 European ancestry individuals from 21 familiesEuropean(339)ALL(339)EUR(339)ALL(339)Plasma factor XI level and activated partial thromboplastin timeHPOID:0001907HPOID:0004936ThromboembolismVenous thrombosisDOID:2452thrombophiliaNANANANAThrombophiliaNAResearch Support, Non-U.S. Gov't
3186454180rs5030062ACrs5030062227010192.19E-09NANANA339 European ancestry individuals from 21 familiesEuropean(339)ALL(339)EUR(339)ALL(339)Plasma factor XI level and activated partial thromboplastin timeHPOID:0001907HPOID:0004936ThromboembolismVenous thrombosisDOID:2452thrombophiliaNANANANAThrombophiliaNAResearch Support, Non-U.S. Gov't
3186455546rs5030072TCrs5030072227010190.000188NANANA339 European ancestry individuals from 21 familiesEuropean(339)ALL(339)EUR(339)ALL(339)Plasma factor XI level and activated partial thromboplastin timeHPOID:0001907HPOID:0004936ThromboembolismVenous thrombosisDOID:2452thrombophiliaNANANANAThrombophiliaNAResearch Support, Non-U.S. Gov't
3186459227rs698078AGrs698078227010190.000155NANANA339 European ancestry individuals from 21 familiesEuropean(339)ALL(339)EUR(339)ALL(339)Plasma factor XI level and activated partial thromboplastin timeHPOID:0001907HPOID:0004936ThromboembolismVenous thrombosisDOID:2452thrombophiliaNANANANAThrombophiliaNAResearch Support, Non-U.S. Gov't
3186459927rs710446TCrs710446227010197.98E-10NANANA339 European ancestry individuals from 21 familiesEuropean(339)ALL(339)EUR(339)ALL(339)Plasma factor XI level and activated partial thromboplastin timeHPOID:0001907HPOID:0004936ThromboembolismVenous thrombosisDOID:2452thrombophiliaNANANANAThrombophiliaNAResearch Support, Non-U.S. Gov't
4187188094rs4253399TGrs4253399227010196.22E-08NANANA339 European ancestry individuals from 21 familiesEuropean(339)ALL(339)EUR(339)ALL(339)Plasma factor XI level and activated partial thromboplastin timeHPOID:0001907HPOID:0004936ThromboembolismVenous thrombosisDOID:2452thrombophiliaNANANANAThrombophiliaNAResearch Support, Non-U.S. Gov't
4187191787rs4241824GArs4241824227010191.16E-08NANANA339 European ancestry individuals from 21 familiesEuropean(339)ALL(339)EUR(339)ALL(339)Plasma factor XI level and activated partial thromboplastin timeHPOID:0001907HPOID:0004936ThromboembolismVenous thrombosisDOID:2452thrombophiliaNANANANAThrombophiliaNAResearch Support, Non-U.S. Gov't
Mapped by lexical matching(Total Items:0)
(Waiting for update.)
Mapped by homologous gene(Total Items:0)
(Waiting for update.)
Disease ID 587
Disease thrombophilia
Case(Waiting for update.)